Dataset Information

Incidence of community onset MRSA in Australia: least reported where it is Most prevalent.

ABSTRACT: Background:This is the first review of literature and synthesis of data on community onset methicillin resistant Staphylococcus aureus (CO-MRSA) infections in Australia. Incidence of CO-MRSA varies considerably in Australia, depending on geographic and demographic factors. Methods:Data for the rates of MRSA infections were collected from articles identified using PubMed, Scopus, the grey literature and data from State and Federal Government Surveillance Systems. We synthesized data and developed a framework for how data was selected, collated, linked, organized and interpreted. Results:The results of our literature search demonstrates considerable gaps in the reporting of CO-MRSA in Australia. Consequently, total incidences were under reported; however the available data suggests the incidence varied between 44 (Tasmania) and 388 (southern Northern Territory) cases per 100,000 person years. Hospitalised cases of CO-MRSA varied between 3.8 (regional Victoria) and 329 (southern Northern Territory). Taking the median percentage of infections by site for all regions available, skin and soft tissue infections (SSTIs) consisted of 56% of hospitalized CO-MRSA, compared with bacteremias, which represented 14%. No region had a complete data set of CO-MRSA infections treated in out-patient settings and so incidences were underestimates. Nevertheless, estimates of the incidence of CO-MRSA treated outside hospitals varied between 11.3 (Melbourne) and 285 (Northern Territory) per 100,000 person-years. These infections were chiefly SSTIs, although urinary tract infections were also noted.Incidences of CO-MRSA blood-stream infections and outpatient skin and soft tissue infections have been increasing with time, except in Tasmania. CO-MRSA is observed to affect people living in remote areas and areas of socioeconomic disadvantage disproportionately. Conclusions:We generated the first estimates of the incidence of CO-MRSA infections in Australia and identified stark regional differences in the nature and frequency of infections. Critically, we demonstrate that there has been a lack of consistency in reporting CO-MRSA and a general dearth of data. The only government in Australia that requires reporting of CO-MRSA is the Tasmanian, where the infection was least prevalent. Some regions of Australia have very high incidences of CO-MRSA. To improve surveillance and inform effective interventions, we recommend a standardized national reporting system in Australia that reports infections at a range of infection sites, has broad geographic coverage and consistent use of terminology. We have identified limitations in the available data that hinder understanding the prevalence of CO-MRSA.

SUBMITTER: Cameron JK

PROVIDER: S-EPMC6373119 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Incidence of community onset MRSA in Australia: least reported where it is Most prevalent.

Cameron Jessica K JK Hall Lisa L Tong Steven Y C SYC Paterson David L DL Halton Kate K

Antimicrobial resistance and infection control 20190212

<h4>Background</h4>This is the first review of literature and synthesis of data on community onset methicillin resistant <i>Staphylococcus aureus</i> (CO-MRSA) infections in Australia. Incidence of CO-MRSA varies considerably in Australia, depending on geographic and demographic factors.<h4>Methods</h4>Data for the rates of MRSA infections were collected from articles identified using PubMed, Scopus, the grey literature and data from State and Federal Government Surveillance Systems. We synthesi ...[more]

PMID: 30805180

Similar Datasets

Project description:BackgroundThe occurrence of livestock-associated (LA) MRSA (ST398) in pig herds has emerged as a threat to occupational safety in many parts of the world. Recently, an outbreak of skin lesions due to MRSA occurred in workers at a pig farm in regional Australia and both the humans and pigs were shown to have a high prevalence of carriage of either the human-strain ST93 or porcine strain ST398. This study closely scrutinises this outbreak to determine factors associated with MRSA carriage amongst the workers.MethodsInformation on potential risk factors was collected from employees by means of a questionnaire. The carriage status of MRSA by workers was assessed by nasal swabs processed using standard laboratory techniques with confirmed isolates subjected to sequence typing. Associations between MRSA carriage in workers and their questionnaire responses were investigated using univariable and multivariable logistic regression.ResultsNasal carriage of MRSA was identified in 60% (31/52) of participants. Workers having contact with pigs had 24 times the odds of MRSA carriage compared to workers with no direct contact (OR 23.6; CI 5.2-172.8). In addition, the probability of MRSA carriage in workers was significantly (P < 0.001) associated with the number of hours in contact with pigs and each hour of contact-time per day increased the risk of MRSA carriage by 1.44 times (CI 1.14-1.96). These associations were significant (P < 0.001) for both strains, ST398 and ST93, present on this farm. Using a multivariable logistic regression model that incorporated human exposure to five different pig age groups (dry sows, farrowing, weaner, grower, and finisher) as fixed effects, a significant (P = 0.027) increased odds of MRSA carriage was found for persons working with farrowing sows compared with those who did not (OR 6.39, CI 1.23-39.36).ConclusionsThis study shows that workers in close contact with pigs on a pig farm where MRSA is present had a higher risk of MRSA carriage as the number of hours of direct contact with pigs increased. Since we have detected a significant association for the human-derived CA-MRSA ST93, similar to the pig-adapted LA-MRSA ST398, we consider ST93 as a potential occupational risk for piggery workers. The risk of MRSA carriage is greatest when working with the farrowing group; therefore, an emphasis is required on personal protective equipment while working in the farrowing house. The study has ramifications for the conduct of surveillance for MRSA in people exposed to pigs.

Project description:Patients with community-onset (CO) methicillin-resistant Staphylococcus aureus (MRSA) infections contribute to MRSA contamination of the home environment and may be reexposed to MRSA strains from this reservoir. This study evaluates One Health risk factors, which focus on the relationship between humans, animals, and the environment, for the increased prevalence of multiple antimicrobial-resistant MRSA isolates in the home environment. During a trial of patients with CO-MRSA infection, MRSA was isolated from the household environment at the baseline and 3 months later, following randomization of patients and household members to mupirocin-based decolonization therapy or an education control group. Up to two environmental MRSA isolates collected at each visit were tested. MRSA isolates were identified in 68% (65/95) of homes at the baseline (n = 104 isolates) and 51% (33/65) of homes 3 months later (n = 56 isolates). The rates of multidrug resistance (MDR) were 61% among isolates collected at the baseline and 55% among isolates collected at the visit 3 months later. At the baseline, 100% (14/14) of MRSA isolates from rural homes were MDR. While antimicrobial use by humans or pets was associated with an increased risk for the isolation of MDR MRSA from the environment, clindamycin use was not associated with an increased risk for the isolation of MDR MRSA. Incident low-level mupirocin-resistant MRSA strains were isolated at 3 months from 2 (5%) of 39 homes that were randomized to mupirocin treatment but none of the control homes. Among patients recently treated for a CO-MRSA infection, MRSA and MDR MRSA were common contaminants in the home environment. This study contributes to evidence that occupant use of antimicrobial drugs, except for clindamycin, is associated with MDR MRSA in the home environmental reservoir. (This study has been registered at ClinicalTrials.gov under registration no. NCT00966446.)IMPORTANCE MRSA is a common bacterial agent implicated in skin and soft tissue infections (SSTIs) in both community and health care settings. Patients with CO-MRSA infections contribute to environmental MRSA contamination in these settings and may be reexposed to MRSA strains from these reservoirs. People interact with natural and built environments; therefore, understanding the relationships between humans and animals as well as the characteristics of environmental reservoirs is important to advance strategies to combat antimicrobial resistance. Household interactions may influence the frequency and duration of exposure, which in turn may impact the duration of MRSA colonization or the probability for recurrent colonization and infection. Therefore, MRSA contamination of the home environment may contribute to human and animal recolonization and decolonization treatment failure. The aim of this study was to evaluate One Health risk factors that may be amenable to intervention and may influence the recovery of MDR and mupirocin resistance in CO-MRSA isolates.

Project description:Background and aimsA concerning rise in incidence of young-onset cancers globally led to the examination of trends in incidence and survival of gastrointestinal (GI) adenocarcinomas in the Northern Territory (NT), Australia, over a 28-year period, with a special emphasis on Indigenous peoples.MethodsThis cross-sectional analysis of a prospective longitudinal database, NT Cancer Registry (1990-2017), includes all reported cases of GI (oesophagus, gastric, small intestinal, pancreas, colon, and rectum) adenocarcinomas. Poisson regression was used to estimate incidence ratio ratios, and survival was modelled using Cox proportional hazard models separately for people aged 18-50 years and >50 years.ResultsA total of 1608 cases of GI adenocarcinoma were recorded during the time of the study. While the overall incidence in people 18-50 years remained unchanged over this time (p = 0.51), the rate in individuals aged >50 years decreased (IRR = 0.65 (95% CI 0.56-0.75; p < 0.0001)). Incidence rates were significantly less in females >50 years (IRR = 0.67 95% CI 0.59-0.75; p < 0.0001), and their survival was significantly better (HR = 0.84 (95%CI 0.72-0.98; p < 0.03)) compared to males. Overall survival across all GI subsites improved in both age cohorts, especially between 2010 and 2017 (HR = 0.45 (95%CI 0.29-0.72; p < 0.0007) and HR = 0.64 (95%CI 0.52-0.78; p < 0.0001), respectively) compared to 1990-1999, driven by an improvement in survival in colonic adenocarcinoma alone, as the survival remained unchanged in other GI subsites. The incidence was significantly lower in Indigenous patients compared to non-Indigenous patients, in both age cohorts (18-50 years IRR = 0.68 95% CI 0.51-0.91; p < 0.009 and >50 years IRR = 0.48 95% CI 0.40-0.57; p < 0.0001). However, Indigenous patients had worse survival rates (18-50 years HR = 2.06 95% CI 1.36-3.11; p < 0.0007 and >50 years HR = 1.66 95% CI 1.32-2.08; p < 0.0001).ConclusionsThere is a trend towards an increased incidence of young-onset GI adenocarcinomas in the NT. Young Indigenous patients have lower incidence but worse survival across all GI subsites, highlighting significant health inequities in life expectancy. Targeted, culturally safe Indigenous community-focussed programs are needed for early detection and patient-centred management of GI adenocarcinomas.

Dataset Information

Incidence of community onset MRSA in Australia: least reported where it is Most prevalent.

Publications

Incidence of community onset MRSA in Australia: least reported where it is Most prevalent.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets